Emmaus Life Sciences, Inc.
- Close
- Aug 31, 2026 · -25.00%
- Market cap
- $4.21M
- 70.19M shares
- Filings
- 1,003
Q2 2026−25.2% FY25 yoy
Q2 2026N/M FY25 yoy
Q2 2026N/M FY25 yoy
Q2 2026derivedN/M FY25 yoy
Q2 2026N/M FY25 yoy
Q2 2026+53.1% FY25 yoy
- $4.21M
- —
- 0.3×
- —
- —
- —
Twelve months to Jun 30, 2026 · derived
Price
Aug 31, 2026 · Official close
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $12,453,000 | reported | |
| FY 2024 | 2024-12-31 | $16,653,000 | reported | |
| FY 2023 | 2023-12-31 | $29,597,000 | reported | |
| FY 2022 | 2022-12-31 | $18,390,000 | reported | |
| FY 2021 | 2021-12-31 | $20,610,000 | reported | |
| FY 2020 | 2020-12-31 | $23,167,000 | reported | |
| FY 2019 | 2019-12-31 | $22,752,000 | reported | |
| FY 2018 | 2018-12-31 | $16,459,000 | reported | |
| FY 2017 | 2017-09-30 | $128,500 | reported |
Segments
Products
LineFY2025ShareChange
Endari - US$9.05M73%−32.9%
Endari - International$3.18M26%+19.1%
Other$225.00K1.8%−55.5%
Endari———
Total$12.45M
Pharmaceutical preparations
Emmaus Life Sciences, Inc. is the 165th largest of the 554 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
ABUSArbutus Biopharma Corp$14.1M128.2%237.9%$617.8MPYXSPyxis Oncology, Inc.$13.9M14.2%574.5%$189.0MCVSICV Sciences, Inc.$13.8M12.2%6.9%$2.3MPTNPalatin Technologies Inc$13.2M—63.5%$12.2MTNXPTonix Pharmaceuticals Holding Corp.$13.1M29.8%946.2%$62.6MEVMNEvommune, Inc.$13.0M85.7%529.8%$241.9M
EMMAEmmaus Life Sciences, Inc. (this company)$12.5M25.2%60.2%$4.2M
PRLDPrelude Therapeutics Inc$12.1M73.4%819.6%$280.9MJAGXJaguar Health, Inc.$11.5M1.5%465.4%$2.0MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Emmaus Life Sciences, Inc. · CIK 822370 · Engraved from SEC EDGAR